We are pleased to announce that the 3rd World Congress on Controversies in Breast Cancer (CoBrCa) will be held in Tokyo, Japan, October 26-28, 2017.
CoBrCa will continue the tradition of directly addressing the key issues facing clinicians in their daily practice. In addition to the key issues in medical oncology, surgery and radiation oncology, CoBrCa will address controversial issues in radiology, pathology and reconstruction, with presentations, debates and discussions. The congress will provide a forum to effectively debate unresolved clinical and therapeutic problems.
We look forward to your participation and contribution in shaping the program and to welcoming you to the exciting metropolis of Tokyo, capital of Japan.
Neoadjuvant therapy
Adjuvant endocrine therapy
Molecular assays
Triple negative breast cancer
Endocrine resistance
Her2 positive breast cancer
Immunotherapy
Breast imaging
Breast cancer screening
Local and locoregional therapy
Breast reconstruction
Breast cancer genetics
Breast cancer 2025
Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).
Creation of a user account is required for the submission of an abstract.
Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance. If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.
The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.
Oct 26
2017
Oct 28
2017
Registration deadline
Submit Comment